Dr. John Christopher Chaloupka, MD

Dr. Chaloupka practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Chaloupka's NPI, 1679564892, was assigned on November 4, 2005. Dr. Chaloupka graduated from The Johns Hopkins University School of Medicine in 1986. Dr. Chaloupka holds Florida license ME109958.

Dr. Chaloupka's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Chaloupka's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. The medical group on file is Mount Sinai Medical Center, Vascular & Interventional Radiology. Dmand AI also links Dr. Chaloupka to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chaloupka practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Chaloupka's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Chaloupka is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Chaloupka's licenses on file in 6 states: Florida, California, Minnesota, Iowa, Connecticut and Georgia.

CMS data shows 725 Medicare services from Dr. Chaloupka across 15 procedure codes in 2024, for 117 Medicare patients. Medicare paid $101,277 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Dr. Chaloupka in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chaloupka's median patient age at 70, with 53% women.

In 2024, Dr. Chaloupka wrote 13 Medicare Part D claims. They cover 1 drug, with $218 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chaloupka for performance year 2024, reported as part of a group. Dr. Chaloupka accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 68 papers to Dr. Chaloupka, published from 2001 to 2020. 2001 was the busiest year, with 4. The most frequent topics are Embolization, Therapeutic, Magnetic Resonance Imaging and Tomography, X-Ray Computed. Dr. Chaloupka has published most often in AJNR Am J Neuroradiol. Dr. Chaloupka's most frequent co-authors are Christopher M. Putman, MD, Walter S. Lesley, MD and Robert Anthony Taylor, MD.

Dmand AI links Dr. Chaloupka to 1 clinical trial. Conditions studied include Intracranial Arteriosclerosis and Intracranial Arterial Diseases.

CMS Open Payments shows 1,351 general payments to Dr. Chaloupka from 29 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 29% of the total. MicroVention, Inc. paid the most, $145,611. It also lists 3 research payments totaling $10,155 from 2016 to 2017.

Dmand AI lists 2 awards for Dr. Chaloupka, most recently Regional Top Doctor in 2014.

Dr. Chaloupka graduated from The Johns Hopkins University School of Medicine in 1986.

Dr. Chaloupka is in network with 5 carriers, including Molina, United Healthcare and Alliant Health Plans. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.